p38 MAPK Regulates IL‐1β Induced IL‐6 Expression Through mRNA Stability in Osteoblasts

References

• Bellido T., Jilka R. L., Boyce B. F., Girasole G., Broxmeyer H., Dalrymple S. A., Murray R., Manolagas S. C. Regulation of interleukin‐6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J. Clin. Invest. 1995; 95: 2886–2895, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bevilacqua A., Ceriani M. C., Capaccioli S., Nicolin A. Post‐transcriptional regulation of gene expression by degradation of messenger RNAs. J. Cell. Physiol. 2003; 195: 356–372, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Blenis J. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 5889–5892, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chae H. J., Chae S. W., Chin H. Y., Bang B. G., Cho S. B., Han K. S., Kim S. C., Tae K. C., Lee K. H., Kim D. E., Im M. K., Lee S. J., Chang J. Y., Lee Y. M., Kim H. M., Kim H. H., Lee Z. H., Kim H. R. The p38 mitogen‐activated protein kinase pathway regulates interleukin‐6 synthesis in response to tumor necrosis factor in osteoblasts. Bone 2001a; 28: 45–53, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Chae H. J., Kim S. C., Chae S. W., An N. H., Kim H. H., Lee Z. H., Kim H. R. Blockade of the p38 mitogen‐activated protein kinase pathway inhibits inducible nitric oxide synthase and interleukin‐6 expression in MC3T3E‐1 osteoblasts. Pharmacol. Res. 2001b; 43: 275–283, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Chaudhary L. R., Spelsberg T. C., Riggs B. L. Production of various cytokines by normal human osteoblast‐like cells in response to interleukin‐1 beta and tumor necrosis factor‐alpha: lack of regulation by 17 beta‐estradiol. Endocrinology 1992; 130: 2528–2534, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Chen C. Y., Xu N., Shyu A. B. mRNA decay mediated by two distinct AU‐rich elements from c‐fos and granulocyte‐macrophage colony‐stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol. Cell. Biol. 1995; 15: 5777–5788, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Clerk A., Harrison J. G., Long C. S., Sugden P. H. Pro‐inflammatory cytokines stimulate mitogen‐activated protein kinase subfamilies, increase phosphorylation of c‐Jun and ATF2 and upregulate c‐Jun protein in neonatal rat ventricular myocytes. J. Mol. Cell. Cardiol. 1999; 31: 2087–2099, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Cobb M. H., Goldsmith E. J. How MAP kinases are regulated. J. Biol. Chem. 1995; 270: 14843–14846, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cuenda A., Rouse J., Doza Y. N., Meier R., Cohen P., Gallagher T. F., Young P. R., Lee J. C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1. FEBS Lett. 1995; 364: 229–233, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Dani C., Piechaczyk M., Audigier Y., El Sabouty S., Cathala G., Marty L., Fort P., Blanchard J. M., Jeanteur P. Characterization of the transcription products of glyceraldehyde 3‐phosphate‐dehydrogenase gene in HeLa cells. Eur. J. Biochem. 1984; 145: 299–304, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Feyen J. H., Elford P., Di Padova F. E., Trechsel U. Interleukin‐6 is produced by bone and modulated by parathyroid hormone. J. Bone Miner. Res. 1989; 4: 633–638, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Girasole G., Jilka R. L., Passeri G., Boswell S., Boder G., Williams D. C., Manolagas S. C. 17 Beta‐estradiol inhibits interleukin‐6 production by bone marrow‐derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 1992; 89: 883–891, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gouble A., Morello D. Synchronous and regulated expression of two AU‐binding proteins, AUF1 and HuR, throughout murine development. Oncogene 2000; 19: 5377–5384, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Grzybowska E. A., Wilczynska A., Siedlecki J. A. Regulatory functions of 3′UTRs. Biochem. Biophys. Res. Commun. 2001; 288: 291–295, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Hedges J. C., Singer C. A., Gerthoffer W. T. Mitogen‐activated protein kinases regulate cytokine gene expression in human airway myocytes. Am. J. Respir. Cell Mol. Biol. 2000; 23: 86–94, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hofbauer L. C., Khosla S., Dunstan C. R., Lacey D. L., Boyle W. J., Riggs B. L. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J. Bone Miner. Res. 2000; 15: 2–12, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ishimi Y., Miyaura C., Jin C. H., Akatsu T., Abe E., Nakamura Y., Yamaguchi A., Yoshiki S., Matsuda T., Hirano T., Kishimoto T., Suda T. IL‐6 is produced by osteoblasts and induces bone resorption. J. Immunol. 1990; 145: 3297–3303, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Iwai Y., Bickel M., Pluznik D. H., Cohen R. B. Identification of sequences within the murine granulocyte‐macrophage colony‐stimulating factor mRNA 3′‐untranslated region that mediate mRNA stabilization induced by mitogen treatment of EL‐4 thymoma cells. J. Biol. Chem. 1991; 266: 17959–17965, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Jilka R. L., Hangoc G., Girasole G., Passeri G., Williams D. C., Abrams J. S., Boyce B., Broxmeyer H., Manolagas S. C. Increased osteoclast development after estrogen loss: mediation by interleukin‐6. Science 1992; 257: 88–91, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Jilka R. L., Weinstein R. S., Bellido T., Parfitt A. M., Manolagas S. C. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J. Bone Miner. Res. 1998; 13: 793–802, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kannabiran C., Zeng X., Vales L. D. The mammalian transcriptional repressor RBP (CBF1) regulates interleukin‐6 gene expression. Mol. Cell. Biol. 1997; 17: 1–9, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Kim G. S., Kim C. H., Choi C. S., Park J. Y., Lee K. U. Involvement of different second messengers in parathyroid hormone‐ and interleukin‐1‐induced interleukin‐6 and interleukin‐11 production in human bone marrow stromal cells. J. Bone Miner. Res. 1997; 12: 896–902, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Kirkwood K., Martin T., Andreadis S. T., Kim Y. J. Chemically modified tetracyclines selectively inhibit IL‐6 expression in osteoblasts by decreasing mRNA stability. Biochem. Pharmacol. 2003; 66: 1809–1819, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Kondo A., Koshihara Y., Togari A. Signal transduction system for interleukin‐6 synthesis stimulated by lipopolysaccharide in human osteoblasts. J. Interferon Cytokine Res. 2001; 21: 943–950, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Kontoyiannis D., Pasparakis M., Pizarro T. T., Cominelli F., Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU‐rich elements: implications for joint and gut‐associated immunopathologies. Immunity 1999; 10: 387–398, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kumar S., Votta B. J., Rieman D. J., Badger A. M., Gowen M., Lee J. C. IL‐1‐ and TNF‐induced bone resorption is mediated by p38 mitogen activated protein kinase. J. Cell. Physiol. 2001; 187: 294–303, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Manolagas S. C., Kousteni S., Jilka R. L. Sex steroids and bone. Recent Prog. Horm. Res. 2002; 57: 385–409, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Marshall C. J. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 1994; 4: 82–89, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Matsumoto M., Sudo T., Saito T., Osada H., Tsujimoto M. Involvement of p38 mitogen‐activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF‐kappa B ligand (RANKL). J. Biol. Chem. 2000; 275: 31155–31161, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Matsusaka T., Fujikawa K., Nishio Y., Mukaida N., Matsushima K., Kishimoto T., Akira S. Transcription factors NF‐IL6 and NF‐kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 10193–10197, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Miyazawa K., Mori A., Miyata H., Akahane M., Ajisawa Y., Okudaira H. Regulation of interleukin‐1beta‐induced interleukin‐6 gene expression in human fibroblast‐like synoviocytes by p38 mitogen‐activated protein kinase. J. Biol. Chem. 1998; 273: 24832–24838, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nabors L. B., Gillespie G. Y., Harkins L., King P. H. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine‐ and uridine‐rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res. 2001; 61: 2154–2161, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Neininger A., Kontoyiannis D., Kotlyarov A., Winzen R., Eckert R., Volk H. D., Holtmann H., Kollias G., Gaestel M. MK2 targets AU‐rich elements and regulates biosynthesis of tumor necrosis factor and interleukin‐6 independently at different post‐transcriptional levels. J. Biol. Chem. 2002; 277: 3065–3068, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ng S. B., Tan Y. H., Guy G. R. Differential induction of the interleukin‐6 gene by tumor necrosis factor and interleukin‐1. J. Biol. Chem. 1994; 269: 19021–19027, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Ragheb J. A., Deen M., Schwartz R. H. The destabilization of IL‐2 mRNA by a premature stop codon and its differential stabilization by trans‐acting inhibitors of protein synthesis do not support a role for active translation in mRNA stability. J. Immunol. 1999; 163: 3321–3330, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Raingeaud J., Gupta S., Rogers J. S., Dickens M., Han J., Ulevitch R. J., Davis R. J. Pro‐inflammatory cytokines and environmental stress cause p38 mitogen‐activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 1995; 270: 7420–7426, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ray A., Sassone‐Corsi P., Sehgal P. B. A multiple cytokine‐ and second messenger‐responsive element in the enhancer of the human interleukin‐6 gene: similarities with c‐fos gene regulation. Mol. Cell. Biol. 1989; 9: 5537–5547, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ridley S. H., Dean J. L., Sarsfield S. J., Brook M., Clark A. R., Saklatvala J. A p38 MAP kinase inhibitor regulates stability of interleukin‐1‐induced cyclooxygenase‐2 mRNA. FEBS Lett. 1998; 439: 75–80, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ridley S. H., Sarsfield S. J., Lee J. C., Bigg H. F., Cawston T. E., Taylor D. J., DeWitt D. L., Saklatvala J. Actions of IL‐1 are selectively controlled by p38 mitogen‐activated protein kinase: regulation of prostaglandin H synthase‐2, metalloproteinases, and IL‐6 at different levels. J. Immunol. 1997; 158: 3165–3173, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rousseau S., Morrice N., Peggie M., Campbell D. G., Gaestel M., Cohen P. Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP‐K2 and its interaction with cytokine mRNAs. EMBO J. 2002; 21: 6505–6514, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sachs A. B. Messenger RNA degradation in eukaryotes. Cell 1993; 74: 413–421, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sanders J. L., Stern P. H. Protein kinase C involvement in interleukin‐6 production by parathyroid hormone and tumor necrosis factor‐alpha in UMR‐106 osteoblastic cells. J. Bone Miner. Res. 2000; 15: 885–893, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Scheidt‐Nave C., Bismar H., Leidig‐Bruckner G., Woitge H., Seibel M. J., Ziegler R., Pfeilschifter J. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J. Clin. Endocrinol. Metab. 2001; 86: 2032–2042, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM‐CSF mRNA mediates selective mRNA degradation. Cell 1986; 46: 659–667, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Srivastava B. I., Srivastava A., Srivastava M. D. Phenotype, genotype and cytokine production in acute leukemia involving progenitors of dendritic Langerhans' cells. Leuk. Res. 1994; 18: 499–511, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Stanton L. A., Sabari S., Sampaio A. V., Underhill T. M., Beier F. p38 MAP kinase signaling is required for hypertrophic chondrocyte differentiation. Biochem. J. 2003; Pt.
   Google Scholar
• Stoecklin G., Hahn S., Moroni C. Functional hierarchy of AUUUA motifs in mediating rapid interleukin‐3 mRNA decay. J. Biol. Chem. 1994; 269: 28591–28597, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stoecklin G., Stoeckle P., Lu M., Muehlemann O., Moroni C. Cellular mutants define a common mRNA degradation pathway targeting cytokine AU‐rich elements. RNA 2001; 7: 1578–1588, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sully G., Dean J. L., Wait R., Rawlinson L., Santalucia T., Saklatvala J., Clark A. R. Structural and functional dissection of a conserved destabilizing element of cyclooxygenase 2 mRNA: evidence against involvement of AUF‐1, AUF‐2, TTP, HuR or FBP1. Biochem. J. 2003; Pt.
   Google Scholar
• Webb S. J., McPherson J. R., Pahan K., Koka S. Regulation of TNF‐alpha‐induced IL‐6 production in MG‐63 human osteoblast‐like cells. J. Dent. Res. 2002; 81: 17–22, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Wesselborg S., Bauer M. K., Vogt M., Schmitz M. L., Schulze‐Osthoff K. Activation of transcription factor NF‐kappaB and p38 mitogen‐activated protein kinase is mediated by distinct and separate stress effector pathways. J. Biol. Chem. 1997; 272: 12422–12429, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Winzen R., Kracht M., Ritter B., Wilhelm A., Chen C. Y., Shyu A. B., Muller M., Gaestel M., Resch K., Holtmann H. The p38 MAP kinase pathway signals for cytokine‐induced mRNA stabilization via MAP kinase‐activated protein kinase 2 and an AU‐rich region‐targeted mechanism. EMBO J. 1999; 18: 4969–4980, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar